Kidney patients on dialysis: new study checks blood thinner safety
NCT ID NCT04006093
First seen Apr 05, 2026 · Last updated May 23, 2026 · Updated 7 times
Summary
This study looked at how a single dose of the blood thinner apixaban is processed in the body of people with end-stage kidney disease who are on peritoneal dialysis, compared to people with normal kidney function. A total of 24 adults took part. The goal was to measure drug levels in the blood over time to help guide safe dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RENAL INSUFFICIENCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Caen
Caen, 14000, France
Conditions
Explore the condition pages connected to this study.